Docmycin Injection is a pioneering lyophilised formulation of Doxycycline for Injection USP, specially developed for veterinary use in dogs and cats. It is a parenteral broad-spectrum tetracycline-class antibiotic, ideal for treating serious systemic infections where oral administration is not possible or effective.
Docmycin is clinically validated as the drug of choice for treating vector-borne diseases like Ehrlichiosis, Anaplasmosis, and Leptospirosis, particularly during the acute and febrile phases. It is formulated by Alembic, one of India’s leading pharmaceutical manufacturers, and offers a standardised, pet-appropriate injectable dose – a first of its kind in veterinary therapeutics.
A landmark study conducted by Madras Veterinary College, TANUVAS (India) demonstrated 100% efficacy of Docmycin over a 14-day period in 62 dogs diagnosed with Ehrlichia canis and Anaplasma platys, showing significant improvements in haematological profiles.
This product is recommended by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ and is proudly listed on PᴇᴛsLɪғᴇsᴛʏʟᴇ for trusted veterinary care.
Composition:
Indications:
-
Canine Monocytic Ehrlichiosis (E. canis)
-
Canine Anaplasmosis (A. platys)
-
Leptospirosis
-
Rickettsial and other tick-borne bacterial infections
-
Severe systemic infections when oral route is not feasible
Benefits:
-
First injectable doxycycline for pets in India
-
Pet-specific dose standardisation (100 mg & 200 mg)
-
Fast-acting and effective during acute stages
-
Clinically validated in over 60 positive canine cases
-
Rapid improvement in:
Dosage & Administration:
Other Details:
-
Route: IV Infusion only
-
Form: Lyophilised Powder
-
Available Strengths: 100 mg & 200 mg vials
-
Brand: Alembic
-
Storage: Store below 25°C. Protect from light and moisture.
-
Note: Use under supervision of a qualified pet expert only.
-
Available at: www.pets-lifestyle.com
